All Vaccinology articles – Page 3
-
NewsStudy shows differences between documented and self-reported polio vaccination rates
Until poliovirus is eradicated worldwide, vaccination protection is important as the virus could be reintroduced at any time. Epidemiologists have now shown that many people in Germany do not know their vaccination status and cannot find it on their vaccination record.
-
NewsReview explores roles, mechanisms and applications of intra-tumoral microbiota in cancers
A recent review provides an overview of the hallmarks, roles, molecular mechanisms, and clinical applications of intra-tumoral microbiota in multiple human cancers.
-
NewsReport explores health, economic, and societal benefits of vaccination
A new report provides evidence on the advantages of immunization for individual and population health, economic outcomes, and societal well-being. Studies show that every $1 spent on childhood vaccines saves about $11 in avoided medical costs and preserved productivity.
-
NewsNew monoclonal antibody shows promise for preventing malaria infections
A new early-stage clinical trial has found that a novel monoclonal antibody provided dose-dependent full protection against the malaria parasite with minimal side effects.
-
NewsStudy finds COVID-19 mRNA vaccine sparks immune response to fight cancer
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
-
NewsSafer, more effective vaccines with new mRNA vaccine technology
A new messenger ribonucleic acid (mRNA) vaccine technology could make future vaccines safer, more effective, and less burdensome for patients. The new approach uses albumin-recruiting lipid nanoparticles to deliver mRNA precisely to lymph nodes while bypassing the liver.
-
NewsScientists research potential anti-ulcer vaccine targeting Helicobacter pylori
Scientists are on the way to finding a vaccine to fight off the Helicobacter pylori bacterium, possibly preventing stomach ulcers and lowering the risk for stomach cancer. They used immunoinformatics to scan its genetic makeup and predict which parts can trigger a strong immune response.
-
NewsMeasles immunity 90% in BC’s Lower Mainland
In British Columbia’s Lower Mainland, 90% of people have detectable antibodies against measles, indicating high vaccine coverage and population protection, according to a new study.
-
NewsTwo-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine
A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The results suggest individuals vaccinated with ZVL should be revaccinated with two doses of RZV.
-
NewsResearchers find key to stopping deadly infection
New research has identified a key step that enables rotavirus to infect cells. The researchers found that disabling the process in tissue culture and in mice prevented infection.
-
NewsNew vaccine shows promise against typhoid and invasive salmonella in first human trial
Researchers have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella–two major causes of illness and death among children in sub-Saharan Africa.
-
NewsBreakthrough results from elephant herpesvirus trial find vaccine to be safe
The world’s first vaccine trial against elephant endotheliotropic herpesvirus (EEHV) – a leading cause of death in young Asian elephants – is safe and triggers a strong virus-fighting immune response, according to a research team.
-
NewsNew herpes virus–based vaccine could cure cancer in the future without side effects
The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes virus can be repurposed as a cancer vaccine.
-
NewsQdenga vaccine shows effectiveness against dengue under real-world conditions during Brazil’s 2024 outbreak
An international team of researchers has demonstrated that the tetravalent dengue vaccine Qdenga provides significant protection against the disease under real-world conditions, during the large 2024 epidemic in São Paulo, Brazil.
-
NewsUnder half in US would recommend some routine vaccinations during pregnancy
Data from a new APPC health survey finds a reluctance among the public to recommend that someone who is pregnant get a Covid-19 vaccine, with just 38% saying they would do so. Less than half of the survey respondents (42%) say it is safe to take an mRNA Covid-19 vaccine during pregnancy.
-
NewsRisk of long COVID in kids doubles after second infection
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, results running counter to the popular perceptions that COVID in children is ‘mild’.
-
NewsStudy shows HPV vaccine protects vaccinated — and unvaccinated — women
A study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine.
-
NewsRSV vaccines safe and effective, Cochrane review finds
A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting vulnerable groups that are most at risk of serious illness, including older adults and infants.
-
NewsMeta-analysis: COVID-19 vaccination during pregnancy is safe and beneficial for mother and infant
Vaccination is associated with better neonatal outcomes without added maternal risk, according to research presented during the American Academy of Pediatrics 2025 National Conference & Exhibition.
-
NewsCholera vaccination campaign launched in Darfur to protect over 1.8 million people
A cholera vaccination campaign kicked off on 21 September 2025 in South Darfur, marking the start of a campaign that aims to reach 1.86 million people aged one year and older with oral vaccines in response to the ongoing outbreak.